Local Institution - 502

Shinjuku 160-0023

0 studies enrolling now · 1 studies all time

What they study most

Dermatitis, Atopic, Eczema

Studies at this site

• A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis — Completed